Given the severity of the current imbalance between blood donor supply and recipient demand, discarded blood drawn from the routine venesections of haemochromatosis (HFE-HH) patients may serve as a valuable alternative source for blood banks and transfusion. We investigated whether functional or biochemical differences existed between HFE-HH and control blood samples, with particular focus upon the haemorheological properties, to investigate the viability of venesected blood being subsequently harvested for blood products.) on haemorheology in healthy blood samples (n = 7). Dependent variables included basic haematology, iron status, haematocrit, red blood cell (RBC) aggregation (native and standardised haematocrit) and “aggregability” (RBC...
The foci of this work were in characterizing and speciating the low molecular mass (LMM) iron pool i...
BackgroundFrequent whole blood donations increase the prevalence of iron depletion in blood donors, ...
Current treatment for newly diagnosed patients with hereditary hemochromatosis (HH) and iron overloa...
SummaryHemochromatosis is a disorder of the iron metabolism, characterized by high body iron content...
Detection of HFE Haemochromatosis (HH) is challenging in the absence of clinical features. HH subjec...
It is well-known that individuals with increased iron levels are more prone to thrombotic diseases, ...
BACKGROUND: Therapeutic phlebotomy is the preferred treatment for iron overload associated with hemo...
It has been demonstrated that iron and iron compounds facilitate hydroxyl radical generation from ac...
Detection of HFE Haemochromatosis (HH) is challenging in the absence of clinical features. HH subjec...
Bio-interactions between a material and blood govern the compatibility of the material with the huma...
In the UK, 90% of patients with hereditary haemochromatosis (HH) are homozygous for HFE C282Y, as ar...
The potential effect of iron depletion by blood donation and its relevance to cardiovascular disease...
Background and aims: Blood banks in Norway struggle to close the gap between need and supply of bloo...
Iron overload in haemoglobinopathies and rare anaemias may develop from increased iron absorption se...
Haemochromatosis is defined as systemic iron overload of genetic origin, caused by a reduction in th...
The foci of this work were in characterizing and speciating the low molecular mass (LMM) iron pool i...
BackgroundFrequent whole blood donations increase the prevalence of iron depletion in blood donors, ...
Current treatment for newly diagnosed patients with hereditary hemochromatosis (HH) and iron overloa...
SummaryHemochromatosis is a disorder of the iron metabolism, characterized by high body iron content...
Detection of HFE Haemochromatosis (HH) is challenging in the absence of clinical features. HH subjec...
It is well-known that individuals with increased iron levels are more prone to thrombotic diseases, ...
BACKGROUND: Therapeutic phlebotomy is the preferred treatment for iron overload associated with hemo...
It has been demonstrated that iron and iron compounds facilitate hydroxyl radical generation from ac...
Detection of HFE Haemochromatosis (HH) is challenging in the absence of clinical features. HH subjec...
Bio-interactions between a material and blood govern the compatibility of the material with the huma...
In the UK, 90% of patients with hereditary haemochromatosis (HH) are homozygous for HFE C282Y, as ar...
The potential effect of iron depletion by blood donation and its relevance to cardiovascular disease...
Background and aims: Blood banks in Norway struggle to close the gap between need and supply of bloo...
Iron overload in haemoglobinopathies and rare anaemias may develop from increased iron absorption se...
Haemochromatosis is defined as systemic iron overload of genetic origin, caused by a reduction in th...
The foci of this work were in characterizing and speciating the low molecular mass (LMM) iron pool i...
BackgroundFrequent whole blood donations increase the prevalence of iron depletion in blood donors, ...
Current treatment for newly diagnosed patients with hereditary hemochromatosis (HH) and iron overloa...